Preparation method and application of a multi-action nanomaterial with targeted photothermal therapy and controlled drug release
A nanomaterial, photothermal therapy technology, applied in the directions of non-active ingredients medical preparations, medical preparations containing active ingredients, nanotechnology, etc. Reduce toxic and side effects, achieve drug release, and achieve the effect of tumor tissue-specific accumulation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] Example 1 Preparation of multi-action nanomaterials with targeted photothermal therapy and controlled drug release
[0045] A method for preparing a multi-action nanomaterial with targeted photothermal therapy and controlled drug release, the steps are as follows:
[0046] (1) Preparation of polydopamine nanomaterials
[0047] Take 1.5mL of ammonia water (mass concentration 25-28%), 45mL of absolute ethanol, and 80mL of deionized water in a round bottom flask, and stir at 35°C for 20 minutes to obtain ammonia water / ethanol / deionized aqueous solution; weigh dopamine hydrochloride (purchased Dissolve 30 mg from Sigma-Aldrich, H8502-5G) in 10 mL of deionized water to obtain an aqueous solution of dopamine hydrochloride; add the aqueous solution of dopamine hydrochloride to the above-mentioned ammonia / ethanol / deionized aqueous solution, and react with stirring at 35°C and 150 rpm for 30 hours After the reaction, centrifuge at 8000rpm for 30 minutes to collect the precipita...
Embodiment 2
[0061] The light-to-heat conversion performance of the polydopamine nanomaterial that the glucose link of embodiment 2
[0062] (1) Configuration of the reaction system
[0063] Weigh 10 mg of the glucose-linked polydopamine nanomaterial prepared in step (2) of Example 1, disperse in 10 mL of phosphate (PBS) buffer, and serially dilute to obtain 10 μg / mL, 20 μg / mL, 50 μg / mL, 100 μg / mL and 200μg / mL suspension. In the experimental group, 200 μL of glucose-linked polydopamine nanomaterial suspension was added to a single well of a 96-well plate; in the control group, 200 μL of PBS buffer was added to a single well of a 96-well plate;
[0064] (2) Test of light-to-heat conversion performance
[0065] The near-infrared light emitted by the BST808-5-F laser in the experimental group and the control group was 3.6W / cm 2 Irradiate for 5 minutes under the same conditions, and use an electronic thermometer to measure and record the temperature change every 30 seconds. The results are ...
Embodiment 3
[0066] Example 3 Drug release of multi-action nanomaterials with targeted photothermal therapy and controlled drug release under different pH conditions
[0067] Weighed 20 mg of the multiple-action nanomaterial with targeted photothermal therapy and controlled drug release prepared in Example 1, resuspended with 4 mL of PBS buffer (10 mM, pH 7.4, containing 0.1% Tween20), and set up 3 repeated experiments, For each experiment, 1 mL of multi-action nanomaterial suspension with targeted photothermal therapy and controlled drug release was placed in a dialysis bag (MW: 7000), and the dialysis bag was dialyzed in 10 mL of a 15 mL centrifuge tube and 10 mM dialysate. Set 4 groups of different conditions, including: 1) the dialysate is PBS buffer with pH 7.4; 2) the dialysate is PBS buffer with pH 6.5; 3) the dialysate is PBS buffer with pH 5.0; 4) the dialysate is pH 5.0 PBS buffer solution and near-infrared light (2W / cm2) emitted by BST808-5-F laser 2 ) irradiated for 3 minutes....
PUM
Property | Measurement | Unit |
---|---|---|
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com